Carbohydrate—protein conjugate vaccines

This publication has 41 references indexed in Scilit:

• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002
• Magnitude of Interference after Diphtheria‐Tetanus Toxoids–Acellular Pertussis/Haemophilus influenzaeType b Capsular Polysaccharide–Tetanus Vaccination Is Related to the Number of Doses Administered
  The Journal of Infectious Diseases, 2001
• The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old Children
  New England Journal of Medicine, 2001
• Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
  New England Journal of Medicine, 2001
• Use of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccine for Type II Group BStreptococcusin Healthy Women
  The Journal of Infectious Diseases, 2000
• γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
  Annual Review of Immunology, 2000
• Induction of Immunologic Memory in Gambian Children by Vaccination in Infancy with a Group A plus Group C Meningococcal Polysaccharide-Protein Conjugate Vaccine
  The Journal of Infectious Diseases, 1997
• CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation
  Immunology Today, 1992
• T Cell Regulation of the Antibody Response to Bacterial Polysaccharide Antigens: An Examination of Some General Characteristics and Their Implications
  The Journal of Infectious Diseases, 1992
• Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus
  New England Journal of Medicine, 1988